Brain Cancer Trial, Recruiting NCT06090903 Sponsor: Jonsson Comprehensive Cancer Center Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06090903
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who have been newly diagnosed with, are suspected of having, or have a returning form of a brain tumor called glioblastoma (GBM), where the tumor is actively growing (shown by enhancement on scans), is larger than 1.5 mL, and surgery has been recommended by their medical team
  • People whose glioblastoma has returned must have had the recurrence confirmed more than 3 months after finishing radiation therapy, based on standard brain tumor assessment guidelines (confirm with trial site)

Who may not be able to join:

  • People who are unable to have an MRI scan — for example, those who have a pacemaker or metal implants in their body
  • People who are 18 years of age or younger

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jonsson Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
14 April 2022
Est. completion
18 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Decorin (DCN) expression; DCN expression correlated to ADCL; Incidence of tumors with high diffusion measurements among MES-like cells; DCN expression among Mesenchymal-Like (MES-like) cells

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov